Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Marsh

Showing results (301-310 of 323) with videos related to

Pageof 33
Sort By:
Wellcome Open Research|August 12, 2021
Equity for excellence in academic institutions: a manifesto for changeLauren Wedekind, Andrés Noé, Jolynne Mokaya, et al.
The Lancet. Infectious Diseases|January 18, 2011
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialAlly Olotu, John Lusingu, Amanda Leach, et al.
Frontiers in Immunology|January 9, 2019
KILchip v1.0: A Novel <i>Plasmodium falciparum</i> Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate PrioritizationGathoni Kamuyu, James Tuju, Rinter Kimathi, et al.
The New England Journal of Medicine|December 10, 2008
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of agePhilip Bejon, John Lusingu, Ally Olotu, et al.
Plos One|June 16, 2011
Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assaySusana Campino, Sarah Auburn, Katja Kivinen, et al.
Plos One|December 3, 2010
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian ChildrenJohn Lusingu, Ally Olotu, Amanda Leach, et al.
Nature|December 9, 2021
Malaria protection due to sickle haemoglobin depends on parasite genotypeGavin Band, Ellen M Leffler, Muminatou Jallow, et al.
Human Molecular Genetics|May 1, 2009
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypesAndrew E Fry, Anita Ghansa, Kerrin S Small, et al.
Plos Genetics|May 30, 2013
Imputation-based meta-analysis of severe malaria in three African populationsGavin Band, Quang Si Le, Luke Jostins, et al.
The Lancet. Infectious Diseases|September 7, 2015
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialMichael T White, Robert Verity, Jamie T Griffin, et al.
Pageof 33

Showing results (301-310 of 323) with videos related to

Sort By:
Pageof 33
Wellcome Open Research|August 12, 2021
Equity for excellence in academic institutions: a manifesto for changeLauren Wedekind, Andrés Noé, Jolynne Mokaya, et al.
The Lancet. Infectious Diseases|January 18, 2011
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialAlly Olotu, John Lusingu, Amanda Leach, et al.
Frontiers in Immunology|January 9, 2019
KILchip v1.0: A Novel <i>Plasmodium falciparum</i> Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate PrioritizationGathoni Kamuyu, James Tuju, Rinter Kimathi, et al.
The New England Journal of Medicine|December 10, 2008
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of agePhilip Bejon, John Lusingu, Ally Olotu, et al.
Plos One|June 16, 2011
Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assaySusana Campino, Sarah Auburn, Katja Kivinen, et al.
Plos One|December 3, 2010
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian ChildrenJohn Lusingu, Ally Olotu, Amanda Leach, et al.
Nature|December 9, 2021
Malaria protection due to sickle haemoglobin depends on parasite genotypeGavin Band, Ellen M Leffler, Muminatou Jallow, et al.
Human Molecular Genetics|May 1, 2009
Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypesAndrew E Fry, Anita Ghansa, Kerrin S Small, et al.
Plos Genetics|May 30, 2013
Imputation-based meta-analysis of severe malaria in three African populationsGavin Band, Quang Si Le, Luke Jostins, et al.
The Lancet. Infectious Diseases|September 7, 2015
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialMichael T White, Robert Verity, Jamie T Griffin, et al.
Pageof 33